Kazuki Sakamoto

Novel Membrane Transporter OCTN1 Mediates Multispecific, Bidirectional, and pH-Dependent Transport of Organic Cations

H Yabuuchi, Ikumi Tamai, Jun‐ichi Nezu et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 314 citations

Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models

Nozomu Tanaka, Kazuki Sakamoto, Hiroyuki Okabe et al. · Oncology Reports · 2014 · 140 citations · Full text

Antitumor Activity, Medicine, Tumor Growth +14

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts

Hiroshi Tsukihara, Fumio Nakagawa, Kazuki Sakamoto et al. · Oncology Reports · 2015 · 109 citations · Full text

Combination Chemotherapy, Medicine, Pharmacology +12

New method for prevention of bile leakage after hepatic resection

Akira Hayashibe, Kazuki Sakamoto, Masaya Shinbo et al. · Journal of Surgical Oncology · 2006 · 86 citations

A high-Tc intrinsic Josephson junction emitter tunable from 0.5 to 2.4 terahertz

Takanari Kashiwagi, Kazuki Sakamoto, Hiroyuki Kubo et al. · Applied Physics Letters · 2015 · 73 citations

Thz Photonics, Superconducting Material, Terahertz Technology +22